Skip to content

Anxiety: all studies

Page 496 of 774: studies 4,951 to 4,960 of 7,737, newest first. Back to the anxiety overview

Research

The Impact of Meditation on Academic Performance and Cognitive Abilities

International Journal For Multidisciplinary Research March 20, 2024 Priya Priya

This research paper explores the influence of meditation on academic performance and cognitive abilities among students. Drawing upon a comprehensive review of existing literature and empirical studies, we examine the potential benefits of incorporating meditation practices into educational settings. The paper considers various forms of meditation, such as mindfulness and transcendental...

Guided Online Mindfulness-Based Intervention for Community Residents with Emotional Distress during the COVID-19 Pandemic.

Social Work March 19, 2024 Daniel Kim-Wan Young, Per Carlbring, Daphne Yi-Ting Cheng et al. 1 citation

This study aimed to assess the efficacy of a guided online mindfulness-based intervention (iMBI) for community residents experiencing emotional distress during the COVID-19 pandemic in Hong Kong. In a randomized controlled trial, 64 participants were recruited from collaborating community-based mental health service units in Hong Kong and assigned to either the treatment (n = 32) or control (n...

DOI: 10.1093/sw/swae004 (opens in new tab) Full text (opens in new tab) Chinese societies Emotional distress Mindfulness-based interventions Online interventions +1

Lightening the Mind: Comparing Audiovisual Stimulation and Meditation for Mood and Cognition Enhancement

Research Square March 14, 2024 Micah Johnson, Ninette Simonian, Nicco Reggente preprint

Abstract In this randomized, controlled, and double-blind experiment with a relatively large sample (n = 262), a novel technique of audiovisual stimulation (AVS) was demonstrated to substantially improve self-reported mood states by reducing several negative affects, including anxiety and depression, and enhancing performance on mood-sensitive cognitive tasks. Most of the AVS effects were...

Scanning the new frontier of mental health: psychedelic brain imaging

The Biochemist March 14, 2024 Natalie Ertl, Matthew B. Wall

The use of psychoactive substances for ritual, spiritual and medicinal purposes stretches back into prehistory and has been a common feature of many diverse cultures and societies globally. Psychedelics, with their unique ability to amplify feelings of connectedness and openness, may have also served as tools for promoting tribal cohesion and trust in ancient cultures. Psychedelic is a broad...

DOI: 10.1042/bio_2023_171 (opens in new tab) Full text (opens in new tab) Frontier Brain scanning Mental health Neuroimaging

Altered states of consciousness

March 13, 2024 Susan Blackmore, Emily T. Troscianko 46 citations

Altered states of consciousness (ASCs) are surprisingly hard to define and to measure. Neither ‘subjective’ methods (like verbal reports) nor ‘objective’ measures (such as how the state is induced, or physiological and behavioural criteria) are entirely satisfactory. Attempts to map ASCs are reviewed, including two- or three-dimensional maps such as Tart&s;s and Laureys’, and Hobson&s;s AIM...

Modest Effects of Neurofeedback-Assisted Meditation Using a Wearable Device on Stress Reduction: A Randomized, Double-Blind, and Controlled Study.

Journal of Korean medical science March 11, 2024 Eunyoung Lee, Jung Kyung Hong, Hayun Choi et al. 11 citations

To evaluate the therapeutic effectiveness and safety of a neurofeedback wearable device for stress reduction. A randomized, double-blind, controlled study was designed. Participants had psychological stress with depression or sleep disturbances. They practiced either neurofeedback-assisted meditation (n = 20; female, 15 [75.0%]; age, 49.40 ± 11.76 years) or neurofeedback non-assisted meditation...

Improvements in well-being following naturalistic psychedelic use and underlying mechanisms of change in older adults: A prospective cohort study.

Research Square March 8, 2024 Hannes Kettner, Leor Roseman, Adam Gazzaley et al. 5 citations preprint

Affective symptoms such as anxiety, low mood, and loneliness are prevalent and highly debilitating symptoms among older adults (OA). Serotonergic psychedelics are novel experimental interventions for affective disorders, yet little is known regarding their effects in OA. Using a prospective cohort design, we identified 62 OA (age ≥ 60 years) and 62 matched younger adults (YA) who completed...

Perceived attachment history predicts psychedelic experiences: A naturalistic study

Journal of Psychedelic Studies March 5, 2024 Aaron D. Cherniak, Mario Mikulincer, Joel Gruneau Brulin et al. 7 citations

Abstract Background and aims Emerging research indicates that psychedelics may have therapeutic potential by fostering meaningful experiences that act as “inflection points” in people's narratives of personal development. However, psychedelic research has largely failed to address pertinent developmental considerations. We investigated whether attachment-related variables were associated with...

DOI: 10.1556/2054.2024.00330 (opens in new tab) Full text (opens in new tab) Naturalism Naturalistic observation Developmental psychology

The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation.

European Journal of Pharmacology March 5, 2024 Hugo R Arias, Deborah Rudin, Dustin J. Hines et al. 12 citations

The anxiolytic and sedative-like effects of 3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole (DM506), a non-hallucinogenic compound derived from ibogamine, were studied in mice. The behavioral effects were examined using Elevated O-maze and novelty suppressed feeding (NSFT) tests, open field test, and loss of righting reflex (LORR) test. The results showed that 15 mg/kg DM506 induced acute...

DOI: 10.1016/j.ejphar.2024.176329 (opens in new tab) Full text (opens in new tab) 5-ht2a/2b receptors Anxiolytic activity Ibogaminalog Molecular docking +1

Cannabidiol exhibits anxiolytic-like effects and antipsychotic-like effects in mice models.

Neuroscience Letters March 1, 2024 Guangzhao Shu, Yang He, Jin Suo et al.

Cannabidiol (CBD), a non-psychoactive compound derived from the cannabis plant, has been confirmed to induce anxiolytic-like and antipsychotic-like effects. However, the exact mechanisms remain unclear. This study substantiated CBD's interaction with the 5-HT1A receptor (5-HT1AR) in vitro (CHO cells expressing human 5-HT1AR) and in vivo (rat lower lip retraction test, LLR test). We then...